Back to the Subject ListUnited Mitochondrial Disease Foundation
We welcome any suggested additions to our list.
Last updated: 26-Jun-98
REFERENCE FORMAT: Author Lastname; Firstname; Article Number; Article Title; Journal or Book; Year; Volume; Page Numbers
Anderson ; JJ ; 1427* ; No evidence for altered muscle mitochondrial function in Parkinson's disease. ; Journal of Neurology, Neurosurgery & Psychiatry ; 1993 ; 56(5) ; 477-80
Anglade ; P ; 5681 ; Apoptosis in dopaminergic neurons of the human substantia nigra during normal aging. ; Histol Histopathol ; 1997 ; 12(3) ; 603-10
Barroso ; N ; 1422* ; Respiratory chain enzyme activities in lymphocytes from untreated patients with Parkinson disease. ; Clinical Chemistry ; 1993 ; 39(4) ; 667-9
Benecke ; R ; 2276* ; Electron transfer complexes I and IV of platelets are abnormal in Parkinson's disease but normal in Parkinson-plus syndromes. ; Brain ; 1993 ; 116 ( Pt 6) ; 1451-63
Bindoff ; L.A. ; 2550 ; Mitochondrial Function in Parkinson's Disease. ; Lancet ; 1989 ; 1 ; 49
Bindoff ; LA ; 2310 ; Respiratory chain abnormalities in skeletal muscle from patients with Parkinson's disease. ; Journal of the Neurological Sciences ; 1991 ; 104(2) ; 203-8
Blake ; CI ; 5723 ; Platelet mitochondrial respiratory chain function in Parkinson's disease. ; Mov Disord ; 1997 ; 12(1) ; 3-8
Blandini ; F ; 5724 ; Quantitative study of mitochondrial complex I in platelets of parkinsonian patients. ; Mov Disord ; 1998 ; 13(1) ; 11-5
Blandini ; F ; 3212 ; Glutamate and Parkinson's disease. ; Mol Neurobiol ; 1996 ; 12(1) ; 73-94
Blin ; O ; 2257* ; Mitochondrial respiratory failure in skeletal muscle from patients with Parkinson's disease and multiple system atrophy. ; Journal of the Neurological Sciences ; 1994 ; 125(1) ; 95-101
Brown ; MD ; 3252* ; Mitochondrial DNA sequence analysis of four Alzheimer's and Parkinson's disease patients. ; Am J Med Genet ; 1996 ; 61(3) ; 283-289
Brown ; S ; 5743 ; Aetiology of Parkinson's disease [letter] ; N Z Med J ; 1997 ; 110(1045) ; 216-7
Burkhardt ; CR ; 3067 ; Parkinson's disease: a chronic, low-grade antioxidant deficiency? ; Med Hypotheses ; 1994 ; 43(2) ; 111-114
Cardellach ; F ; 395* ; Mitochondrial respiratory chain activity in skeletal muscle from patients with Parkinson's disease [see comments] Department of General Internal Medicine, Hospital Clinic ; Neurology ; 1993 ; 43(11) ; 2258-62
Cassarino ; DS ; 5757 ; Elevated reactive oxygen species and antioxidant enzyme activities in animal and cellular models of Parkinson's disease. ; Biochim Biophys Acta ; 1997 ; 1362(1) ; 77-86
Cohen ; G ; 5785 ; Parkinson disease: a new link between monoamine oxidase and mitochondrial electron flow. ; Proc Natl Acad Sci U S A ; 1997 ; 94(10) ; 4890-4
Collins ; MA ; 3069 ; Indole-N-methylation of beta-carbolines: the brain's bioactivation route to toxins in Parkinson's disease? ; Ann. N. Y. Acad. Sci. ; 1992 ; 648 ; 263-265
Cooper ; JM ; 5792 ; Mitochondrial dysfunction in neurodegeneration. ; J Bioenerg Biomembr ; 1997 ; 29(2) ; 175-83
DiMauro ; S ; 2645* ; Mitochondrial involvement in Parkinsons's disease: The controversy continues ; Neurology ; 1993 ; 43 ; 2170-2
Djaldetti ; R ; 792 ; Parkinson's disease in a patient with mitochondrial myopathy: is there a causative relationship? [letter]. ; Movement Disorders ; 1992 ; 7(4) ; 382-3
Ebadi ; M ; 3383* ; Oxidative stress and antioxidant therapy in Parkinson's disease. ; Prog Neurobiol ; 1996 ; 48(1) ; 1-19
Egensperger ; R ; 5836 ; Association of the mitochondrial tRNA(A4336G) mutation with Alzheimer's and Parkinson's diseases. ; Neuropathol Appl Neurobiol ; 1997 ; 23(4) ; 315-21
Fischel-Ghodsian ; N ; 5853 ; Mitochondrial genetics and hearing loss: the missing link between genotype and phenotype. ; Proc Soc Exp Biol Med ; 1998 ; 218(1) ; 1-6
Gargalidis-Moudanos ; C ; 5876 ; I2-imidazoline binding sites and monoamine oxidase activity in human postmortem brain from patients with Parkinson's disease. ; Neurochem Int ; 1997 ; 30(1) ; 31-6
Glinka ; Y ; 5880 ; Mechanism of 6-hydroxydopamine neurotoxicity. ; J Neural Transm Suppl ; 1997 ; 50 ; 55-66
Graeber ; MB ; 5887 ; Neurodegeneration and aging: role of the second genome. ; J Neurosci Res ; 1998 ; 52(1) ; 1-6
Graeber ; MB ; 5886 ; Recent developments in the molecular genetics of mitochondrial disorders. ; J Neurol Sci ; 1998 ; 153(2) ; 251-63
Gu ; M ; 5895 ; Mitochondrial respiratory chain function in multiple system atrophy. ; Mov Disord ; 1997 ; 12(3) ; 418-22
Haas ; RH ; 2247* ; Low platelet mitochondrial complex I and complex II/III activity in early untreated Parkinson's disease. ; Annals of Neurology ; 1995 ; 37(6) ; 714-22
Hattori ; N ; 2295* ; Immunohistochemical studies on complexes I, II, III, and IV of mitochondria in Parkinson's disease. ; Advances in Neurology ; 1993 ; 60 ; 292-6
Hattori ; N ; 2309 ; Immunohistochemical studies on complexes I, II, III, and IV of mitochondria in Parkinson's disease. ; Annals of Neurology ; 1991 ; 30(4) ; 563-71
Ikebe ; S ; 3559 ; Point mutations of mitochondrial genome in Parkinson's disease. ; Brain Res Mol Brain Res ; 1995 ; 28(2) ; 281-295
Itoh ; K ; 5947 ; Defects of cytochrome c oxidase in the substantia nigra of Parkinson's disease: and immunohistochemical and morphometric study. ; Mov Disord ; 1997 ; 12(1) ; 9-16
Janetzky ; B. ; 2576* ; Unaltered aconitase activity, but decreased complex I activity in substantia nigra pars compacta of patients with Parkinson's disease. ; Neurosci. Lett. ; 1994 ; 169 ; 126-128
Jenner ; P ; 3079 ; Parkinson's disease: pathological mechanisms and actions of piribedil. ; J. Neurol. ; 1992 ; 239 ; S2-S8
Jenner ; P ; 3078 ; Oxidative stress as a cause of Parkinson's disease. ; Acta Neurol Scand Suppl ; 1991 ; 136 ; 6-15
Jenner ; P ; 5953 ; Oxidative stress and the pathogenesis of Parkinson's disease. ; Neurology ; 1996 ; 47(6 Suppl 3) ; S161-70
Jenner ; P ; 3080 ; What process causes nigral cell death in Parkinson's disease? ; Neurol Clin ; 1992 ; 10(2) ; 387-403
Koller ; WC ; 5996 ; Neuroprotective therapy for Parkinson's disease. ; Exp Neurol ; 1997 ; 144(1) ; 24-8
Kopin ; IJ ; 3083 ; MPTP: an industrial chemical and contaminant of illicit narcotics stimulates a new era in research on Parkinson's disease. ; Environ. Health Perspect. ; 1987 ; 75 ; 45-51
Kordower ; JH ; 5999 ; Functional fetal nigral grafts in a patient with Parkinson's disease: chemoanatomic, ultrastructural, and metabolic studies. ; J Comp Neurol ; 1996 ; 370(2) ; 203-30
Krige ; D ; 3085 ; Platelet mitochondrial function in Parkinson's disease. The Royal Kings and Queens Parkinson Disease Research Group. ; Ann. Neurol. ; 1992 ; 32(6) ; 782-788
Lestienne ; P ; 3087 ; Normal mitochondrial genome in brain from patients with Parkinson's disease and complex I defect ; J. Neurochem. ; 1990 ; 55(5) ; 1810-1812
Lucking ; CB ; 3726* ; Absence of the mitochondrial A7237T mutation in Parkinson's disease. ; Biochem Biophys Res Commun ; 1995 ; 211(2) ; 700-704
Martin ; MA ; 2661* ; Respiratory-chain enzyme activities in isolated mitochondria of lymphocytes from untreated Parkinson's disease patients ; Neurology ; 1996 ; 46(5) ; 1343-6
Matsubara ; K ; 3773* ; beta-Carbolinium cations, endogenous MPP+ analogs, in the lumbar cerebrospinal fluid of patients with Parkinson's disease. ; Neurology ; 1995 ; 45(12) ; 2240-2245
Maurer ; I ; 6060 ; Inhibition of complex I by neuroleptics in normal human brain cortex parallels the extrapyramidal toxicity of neuroleptics. ; Mol Cell Biochem ; 1997 ; 174(1-2) ; 255-9
Melov ; S ; 6075 ; A novel neurological phenotype in mice lacking mitochondrial manganese superoxide dismutase [see comments] ; Nat Genet ; 1998 ; 18(2) ; 159-63
Mizuno ; Y. ; 2597 ; Deficiencies in complex I subunits of the respiratory chain in Parkinson's disease. ; Biochem. Biophys. Res. Commun. ; 1989 ; 163 ; 1450-1455
Mizuno ; Y ; 3806* ; Role of mitochondria in the etiology and pathogenesis of Parkinson's disease. ; Biochim Biophys Acta ; 1995 ; 1271(1) ; 265-274
Mizuno ; Y ; 3088* ; An immunohistochemical study on alpha-ketoglutarate dehydrogenase complex in Parkinson's disease. ; Ann Neurol ; 1994 ; 35(2) ; 204-210
Montgomery EB ; Jr ; 3813 ; Heavy metals and the etiology of Parkinson's disease and other movement disorders. ; Toxicology ; 1995 ; 97(1-3) ; 3-9
Mytilineou ; C ; 2862* ; Impaired oxidative decarboxylation of pyruvate in fibroblasts from patients with Parkinson's disease. ; J Neural Transm Park Dis Dement Sect ; 1994 ; 8(3) ; 223-8
Nagatsu ; T ; 6112 ; Isoquinoline neurotoxins in the brain and Parkinson's disease. ; Neurosci Res ; 1997 ; 29(2) ; 99-111
Naoi ; M ; 3091* ; Novel toxins and Parkinson's disease: N-methylation and oxidation as metabolic bioactivation of neurotoxin. ; J Neural Transm Suppl ; 1994 ; 41 ; 197-205
Parker Jr ; WD ; 2195 ; Preclinical detection of Parkinson's disease: biochemical approaches. [Review] ; Neurology ; 1991 ; 41(5 Suppl 2) ; 34-7
Parker WD ; Jr ; 3094 ; Abnormalities of the electron transport chain in idiopathic Parkinson's disease. ; Ann. Neurol. ; 1989 ; 26(6) ; 719-723
Peers ; R ; 6155 ; Fatty diet, mitochondria and Parkinson's disease [letter] ; N Z Med J ; 1997 ; 110(1041) ; 132
Penn ; AM ; 3940* ; Generalized mitochondrial dysfunction in Parkinson's disease detected by magnetic resonance spectroscopy of muscle. ; Neurology ; 1995 ; 45(11) ; 2097-2099
Radunovic ; A ; 6178 ; Increased mitochondrial superoxide dismutase activity in Parkinson's disease but not amyotrophic lateral sclerosis motor cortex. ; Neurosci Lett ; 1997 ; 239(2-3) ; 105-8
Reichmann ; H ; 949* ; Parkinson's disease and the electron transport chain in postmortem brain. ; Advances in Neurology ; 1993 ; 60 ; 297-9
Ruberg ; M ; 6195 ; Is differential regulation of mitochondrial transcripts in Parkinson's disease related to apoptosis? ; J Neurochem ; 1997 ; 68(5) ; 2098-110
Schapira ; AH ; 1186 ; Evidence for mitochondrial dysfunction in Parkinson's disease--a critical appraisal. [Review] ; Movement Disorders ; 1994 ; 9(2) ; 125-38
Schapira ; AH ; 3099 ; MPTP and other Parkinson-inducing agents. ; Curr Opin Neurol Neurosurg ; 1992 ; 5(3) ; 396-400
Schapira ; AH ; 2738 ; Mitochondrial complex I deficiency in Parkinson's disease. ; J Neurochem ; 1990 ; 54(3) ; 823-7
Schapira ; AH ; 6212 ; Mitochondrial disorders. ; Curr Opin Neurol ; 1997 ; 10(1) ; 43-7
Schapira ; AH ; 4045 ; Oxidative stress in Parkinson's disease. ; Neuropathology & Applied Neurobiology ; 1995 ; 21(1) ; 3-9
Schapira ; AH ; 4044* ; Nuclear and mitochondrial genetics in Parkinson's disease. ; J Med Genet ; 1995 ; 32(6) ; 411-414
Schulz ; JB ; 6221 ; The role of mitochondrial dysfunction and neuronal nitric oxide in animal models of neurodegenerative diseases. ; Mol Cell Biochem ; 1997 ; 174(1-2) ; 193-7
Shan ; DE ; 4067* ; Absence of 4,977-bp deletion of blood cell mitochondrial DNA in patients with young-onset Parkinson's disease. ; Acta Neurol Scand ; 1995 ; 91(2) ; 149-152
Sheehan ; JP ; 6233 ; Altered calcium homeostasis in cells transformed by mitochondria from individuals with Parkinson's disease. ; J Neurochem ; 1997 ; 68(3) ; 1221-33
Shergill ; JK ; 4071* ; Detection of nitrosyl complexes in human substantia nigra, in relation to Parkinson's disease. ; Biochem Biophys Res Commun ; 1996 ; 228(2) ; 298-305
Shimoda-Matsubayashi ; S ; 6237 ; Structural dimorphism in the mitochondrial targeting sequence in the human manganese superoxide dismutase gene. A predictive evidence for conformational change to influence mitochondrial transport and a study of allelic association in Parkinson's ; Biochem Biophys Res Commun ; 1996 ; 226(2) ; 561-5
Shimoda-Matsubayashi ; S ; 6238 ; Mn SOD activity and protein in a patient with chromosome 6-linked autosomal recessive parkinsonism in comparison with Parkinson's disease and control. ; Neurology ; 1997 ; 49(5) ; 1257-62
Shoffner ; J.M. ; 241* ; Mitochondrial Oxidative Phosphorylation Defects in Parkinson's Disease ; Ann Neurol ; 1991 ; 30(3) ; 332-9
Shoffner ; JM ; 1411 ; Mitochondrial DNA variants observed in Alzheimer disease and Parkinson disease patients. ; Genomics ; 1993 ; 17(1) ; 171-84
Shoffner ; JM ; 2624 ; A mitochondrial DNA (mtDNA) mutation associated with maternally inherited Parkinson's disease (PD) and deafness. (abstract 1417) ; American Journal of Human Genetics ; 1994 ; 55 ; A242
Shults ; CW ; 6241 ; Coenzyme Q10 levels correlate with the activities of complexes I and II/III in mitochondria from parkinsonian and nonparkinsonian subjects. ; Ann Neurol ; 1997 ; 42(2) ; 261-4
Shults ; CW ; 2254* ; Carbidopa/levodopa and selegiline do not affect platelet mitochondrial function in early parkinsonism. ; Neurology ; 1995 ; 45(2) ; 344-8
Shults ; CW ; 6242 ; Absorption, tolerability, and effects on mitochondrial activity of oral coenzyme Q10 in parkinsonian patients. ; Neurology ; 1998 ; 50(3) ; 793-5
Suomalainen ; A ; 6282 ; Mitochondrial DNA and disease. ; Ann Med ; 1997 ; 29(3) ; 235-46
Sutton ; JP ; 6285 ; Atypical parkinsonism in a family of Portuguese ancestry: absence of CAG repeat expansion in the MJD1 gene. ; Neurology ; 1997 ; 48(5) ; 1285-90
Swerdlow ; RH ; 3105* ; Origin and functional consequences of the complex I defect in Parkinson's disease. ; Ann Neurol ; 1996 ; 40(4) ; 663-671
Tatton ; WG ; 6310 ; Modulation of gene expression rather than monoamine oxidase inhibition: (-)-deprenyl-related compounds in controlling neurodegeneration. ; Neurology ; 1996 ; 47(6 Suppl 3) ; S171-83
Taylor ; DJ ; 639* ; A 31P magnetic resonance spectroscopy study of mitochondrial function in skeletal muscle of patients with Parkinson's disease. ; Journal of the Neurological Sciences ; 1994 ; 125(1) ; 77-81
Temlett ; JA ; 4167* ; Parkinson's disease: biology and aetiology ; Curr Opin Neurol ; 1996 ; 9(4) ; 303-307
Tranchant ; C ; 4194 ; Idiopathic Parkinson disease and mitochondrial functions ; Rev Neurol (Paris) ; 1995 ; 151(3) ; 157-160
Vieregge ; P ; 3104* ; Genetic factors in the etiology of idiopathic Parkinson's disease. ; J Neural Transm Park Dis Dement Sect ; 1994 ; 8(1-2) ; 1-37
Vila ; M ; 4224* ; Metabolic activity of the basal ganglia in parkinsonian syndromes in human and non-human primates: a cytochrome oxidase histochemistry study. ; Neuroscience ; 1996 ; 71(4) ; 903-912
Wood ; N ; 6379 ; Genes and parkinsonism [editorial] ; J Neurol Neurosurg Psychiatry ; 1997 ; 62(4) ; 305-9
Yamamoto ; M ; 6384 ; Cerebrospinal fluid lactate and pyruvate concentrations in patients with Parkinson's disease and mitochondrial encephalomyopathy, lactic acidosis, and stroke-like episodes (MELAS) [letter] ; J Neurol Neurosurg Psychiatry ; 1997 ; 62(3) ; 290
Yoshino ; H ; 1432 ; Mitochondrial complex I and II activities of lymphocytes and platelets in Parkinson's disease. ; Journal of Neural Transmission - Parkinsons Disease & Dementia Section ; 1992 ; 4(1) ; 27-34